QuickView for frdA;jsessionid=2E2EDE944854D68EAC8414EC89E6AD75;jsessionid=4DF4DABE4C3773B2684541A0B4DC5DED;jsessionid=F41D372FBB365C5AD8666F2B95DF93EB (gene)

1. Generation and characterization of two human iPSC lines, IGIBi014-A and IGIBi015-A, from Friedreich'…
2. Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia.
3. Frataxin deficiency shifts metabolism to promote reactive microglia via glucose catabolism.
4. A modified mouse model of Friedreich's ataxia with conditional Fxn allele homozygosity delays onset …
5. Molecular approaches for the treatment and prevention of Friedreich's ataxia.

There were no clinical trials for frdA;jsessionid=2E2EDE944854D68EAC8414EC89E6AD75;jsessionid=4DF4DABE4C3773B2684541A0B4DC5DED;jsessionid=F41D372FBB365C5AD8666F2B95DF93EB